Government lawyers slam suits from BMS, Janssen over drug price negotiationsnews2023-10-17T18:44:21+00:00October 17th, 2023|Endpoints News|
J&J lays out plans for potential Supreme Court petition in talc litigationnews2023-10-17T18:32:43+00:00October 17th, 2023|Endpoints News|
Q&A: Lilly science chief Dan Skovronsky talks dealmaking, AI and consistent investingnews2023-10-17T17:19:42+00:00October 17th, 2023|Endpoints News|
Amazon’s head of health services shares why consumers could be a disruptive force to the healthcare industrynews2023-10-17T16:27:35+00:00October 17th, 2023|Endpoints News|
Jingle all the way? Pharma marketers adapt their music strategies for channels like TikToknews2023-10-17T16:16:08+00:00October 17th, 2023|Endpoints News|
Apellis’ C3 inhibitor shows biomarker impact in small PhII rare kidney disease trialnews2023-10-17T15:37:09+00:00October 17th, 2023|Endpoints News|
MarketingRx roundup: Americans still divided over Covid boosters; Amgen ramps up activity on Threadsnews2023-10-17T15:29:55+00:00October 17th, 2023|Endpoints News|
Evelo dealt another blow with a PhII fail, plans for strategic alternativesnews2023-10-17T15:21:46+00:00October 17th, 2023|Endpoints News|
Ultragenyx to spin off company to develop ‘high risk, high return’ gene therapy for Alzheimer’s diseasenews2023-10-17T15:17:45+00:00October 17th, 2023|Endpoints News|
Nkarta trims headcount as it sets sights on autoimmune cell therapynews2023-10-17T15:08:07+00:00October 17th, 2023|Endpoints News|
